NCT04221321View on ClinicalTrials.gov

Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

March 12, 2020

Study Completion Date

April 20, 2020

Conditions
Healthy
Interventions
DRUG

Atorvastatin 40 mg

Atorvastatin 40 mg

DRUG

Tegoprazan 50 mg

Tegoprazan 50 mg tablet

DRUG

RAPA114

RAPA114 tablet

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT04221321 - Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter